New hope for MS patients: real-world study tests ofatumumab's impact on nerve damage
NCT ID NCT07353216
First seen Jan 28, 2026 · Last updated May 06, 2026 · Updated 14 times
Summary
This study looks at how well the drug ofatumumab works for people with relapsing multiple sclerosis (RMS) in everyday medical practice. It will measure changes in a blood marker called sNfL, which indicates nerve damage. About 80 adults with RMS will take ofatumumab and be followed for safety and effectiveness. The goal is to see if the drug can reduce nerve damage and help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Third Affiliated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 518000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.